#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cutaneous T-cell lymphoma Immunoglobulin G4 related disease Henoch-Schonlein purpura Pulmonary hypertension Renal cell carcinoma Multifocal motor neuropathy Colon cancer Myasthenia gravis Rheumatoid arthritis Adenoid cystic carcinoma Piriformis syndrome Amyotrophic lateral sclerosis Acute graft versus host disease in liver Granulomatosis with polyangiitis Primary myelofibrosis More trials…

    Learn about Rare Diseases

    Mucopolysaccharidosis I Medulloblastoma recurrent Factor IX deficiency – Trials in Disease Angiosarcoma – Diagnostics Ewing’s sarcoma recurrent – Basic Information Methylmalonic acidaemia Mantle cell lymphoma stage IV Isodicentric chromosome 15 syndrome – Basic Information Medulloblastoma – Diagnostics Langerhans’ cell histiocytosis – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Atropine Sulfate Monohydrate Mepivacaine Hydrochloride Amcenestrant Progesterone Atorvastatin Calcium RP3 Oxycodone Hydrochloride BIIB115 Clopidogrel Pancreas Powder Fluoxetine Astegolimab Lithium Bgb-15025 Citrate Belzupacap Sarotalocan Argon Ampicillin Sodium Niflumic Acid Potassium Canrenoate Mosunetuzumab More therapies…

    Learn about Your Condition

    Short stature Dermatitis Papillary thyroid cancer Pulmonary resection Brain neoplasm Abdominal wall pain Pyelonephritis Urticaria chronic Cardiac failure Spondylolisthesis Microvillous inclusion disease Acute cardiac event Primary hyperaldosteronism Glomerulonephritis acute Cutaneous calcification More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of Citicoline to Prevent Cognitive Decline After Delirium in Older Adults with Hip Fracture

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Cognitive disorder
    Italy

  • Study of ipilimumab, nivolumab, temozolomide and capecitabine in patients with chemotherapy-resistant metastatic colorectal cancer with specific genetic markers

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    Investigated Drugs:
    • Ipilimumab
    • Temozolomide
    • Capecitabine
    Denmark

  • Evaluation of Brain Inflammation Using 18F-DPA-714 PET Imaging in Patients with Intracerebral Hemorrhage

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Cerebral haemorrhage
    France

  • Study comparing oral and injectable nefopam in patients with acute rheumatologic pain to evaluate how the medication is processed by the body

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Pain
    Investigated Drugs:
    • Nefopam Hydrochloride
    France

  • Study of prucalopride and escitalopram combination to improve treatment response in patients with major depressive disorder

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Depression
    Investigated Drugs:
    • Escitalopram
    France

  • Study of Lebrikizumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis to Understand How the Medicine Works

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Lebrikizumab
    Germany
Previous Page
1 … 765 766 767 768 769 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!